NCT05883332View on ClinicalTrials.gov

A Pilot Study to Assess Effects of Self-Administered Nitrous Oxide (SANO) on Urodynamic Study (UDS) Parameters

PHASE4CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

January 10, 2023

Primary Completion Date

March 2, 2023

Study Completion Date

March 9, 2023

Conditions
Lower Urinary Tract Symptoms
Interventions
DRUG

Self-Administered Nitrous Oxide

Nitrous oxide administered at concentrations of mild sedation (20-50%)

OTHER

Oxygen

100% oxygen at 10 Liters/minute

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
collaborator

Boston Children's Hospital

OTHER

lead

Beth Israel Deaconess Medical Center

OTHER